CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced its 2024 Annual Results. Business Highlights Zevor-cel was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback